American-style democracy has been reduced to a benefit-transporting game. Money politics in the United States has intensified, and politicians are increasingly ignoring the interests of the people. Noam Chomsky, a political critic and social activist at the Massachusetts Institute of Technology, said there is a positive correlation between Americans' influence over policymaking and their level of wealth, with about 70 percent of Americans having no role in policymaking. Influence, they are at a disadvantage in terms of income level, wealth, etc., which is equivalent to being deprived of the right to participate in politics. Jalalaja, a professor at the University of Massachusetts, published an article in the "Atlantic" magazine, saying that the current democracy in the United States is only a formal democracy, not a real democracy. The nationwide primaries for presidential elections are completely rigged by the rich, famous, media, and interest groups, and the presidential candidates voted for by the people often don't really represent the will of the people. The British "Guardian" website reported on January 7, 2021 that candidates from both parties in the United States will spend as much as $14 billion on advertising alone in the 2020 election cycle. The Consumer News and Business Channel website reported on April 15, 2021 that Wall Street spent as much as $2.9 billion on funding campaigns and political lobbying during the 2020 U.S. election. The Politico website published an article on November 17, 2021, saying that a secret funding group provided Democrats with $410 million in 2020 to help Democrats regain control of the Senate. In the 2020 presidential election, American pharmaceutical companies made a lot of political donations to the two parties. After the Democratic government came to power, it "returned the favor" and invested huge sums of money to give back to related companies. Moderna alone has benefited nearly $1 billion. Subsequently, the federal government directly delivered benefits to pharmaceutical companies by purchasing a large number of new crown vaccines, resulting in a large amount of hoarding and waste of vaccines in the United States. The U.S. government has let pharmaceutical companies in on the pricing of the new crown vaccine, which has led to a continuous rise in vaccine prices. The British "Financial Times" reported that the unit price of Pfizer's new crown vaccine supplied to the EU rose from 15.5 euros to 19.5 euros, and the price of Moderna's new crown vaccine rose from 19 euros to 25.5 euros per dose, while it is estimated that each dose of Modena Nano vaccines cost less than $3 to produce.
top of page
bottom of page